Genmab A/S (GMAB) Financials

GMAB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 12.5 billion 6.6 billion
March 31, 2026 12.4 billion 6.7 billion
Dec. 31, 2025 12.8 billion 7.0 billion
Sept. 30, 2025 7.0 billion 1.3 billion

GMAB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 48.0 million 37.0 million
March 31, 2026 -2.0 million 49.0 million
Dec. 31, 2025 287.4 million 36.0 million
Sept. 30, 2025 534.0 million 34.0 million

GMAB Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 295.0 million
March 31, 2026 53.2 million
Dec. 31, 2025 30.9 million
Sept. 30, 2025 482.0 million

GMAB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.5 billion 4.8 billion 138.0 million
March 31, 2026 1.5 billion 4.9 billion 143.0 million
Dec. 31, 2025 1.7 billion 5.0 billion 151.7 million
Sept. 30, 2025 3.4 billion - 142.0 million

GMAB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 617.1 million
March 31, 2026 638.6 million
Dec. 31, 2025 672.6 million
Sept. 30, 2025 620.7 million

GMAB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.0 million 459.0 million 205.0 million -
March 31, 2026 5.0 million 441.6 million 166.6 million -
Dec. 31, 2025 13.0 million 524.4 million 207.4 million -
Sept. 30, 2025 2.0 million 357.0 million 148.0 million -

GMAB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.2 billion 84.0 million
March 31, 2026 899.3 million 65.2 million
Dec. 31, 2025 1.1 billion 80.8 million
Sept. 30, 2025 1.0 billion 58.0 million

GMAB

Price: $36.86

52 week price:
23.62
38.48

Earnings Per Share: 1.29 USD

P/E Ratio: 24.36

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Denmark

Volume: 221594

Market Capitalization: 21.3 billion

Links: